-transparent.png){kind=logo}
Blood levels and urinary excretion rates of bethanidine were determined in three normal human subjects following oral administration of a single dose of the drug. The postabsorptive decline of blood concentration with time was noticeably slower than the corresponding decline in the urinary excretion rate. The discrepancy can be attributed to a continual decrease in the renal clearance of bethanidine throughout the study. Therefore, pharmacokinetic modeling of urinary excretion data alone would lead to erroneous conclusions concerning the persistence of drug in the blood.
Related Publications
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
June 2007,
British journal of clinical pharmacology,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
January 1969,
Zeitschrift fur klinische Chemie und klinische Biochemie,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
November 1985,
The Journal of clinical investigation,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
June 2009,
Kidney international,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
January 1994,
Life sciences,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
April 1992,
Clinical pharmacology and therapeutics,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
February 2018,
Clinical & experimental metastasis,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
December 2023,
bioRxiv : the preprint server for biology,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
July 1952,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
A N Chremos, and
D Shen, and
M Gibaldi, and
J D Proctor, and
J H Newman
February 1976,
The American journal of physiology,
